Akso Health (AHG) Cash & Current Investments (2017 - 2025)

Akso Health has reported Cash & Current Investments for 9 years, with the latest figure at $176.2 million in Q3 2025.

• For the quarter ending Q3 2025, Cash & Current Investments rose 106.91% year-over-year to $176.2 million; the trailing twelve-month figure through Sep 2025 stood at $176.2 million (up 106.91% YoY), and the FY2025 full-year result was $176.2 million, up 106.84% from the prior year.
• Cash & Current Investments for Q3 2025 stood at $176.2 million, roughly flat from $176.2 million in the prior quarter.
• The five-year high for Cash & Current Investments was $176.2 million in Q1 2025, with the low at $4491.0 in Q1 2022.
• Historically, Cash & Current Investments has averaged $56.7 million across 5 years, with a median of $12.6 million in 2021.
• Annual changes were most pronounced in 2022 — Cash & Current Investments slumped 99.7% — and 2023, when it jumped 176352.19%.
• Akso Health's Cash & Current Investments stood at $15.1 million in 2021, then sank by 33.96% to $10.0 million in 2022, then declined by 7.8% to $9.2 million in 2023, then surged by 824.63% to $85.2 million in 2024, then surged by 106.91% to $176.2 million in 2025.
• The last three Cash & Current Investments figures came in at $176.2 million (Q3 2025), $176.2 million (Q1 2025), and $85.2 million (Q3 2024), per Business Quant data.